Phase II trials
Clinical Trials Watch
This section contains information about clinical trials that are:
- Currently recruiting participants
- Conducted at least in one European country
- In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)
How many Phase II trials are reported in the CTW?
The CTW reports currently 10 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:
| Study | Study sponsor | Name of the drug | Condition |
| ACI-35-1802 | AC Immune | ACI-35.030 or JACI-35.054 | Early Alzheimer's disease |
| ALZ-801 | Alzheon Inc. | ALZ-801 | Early Alzheimer's disease |
| Janssen | JNJ-63733657 | Early Alzheimer's disease |
|
| Brainshuttle AD | Hoffmann-La Roche | RO7126209 | Prodromal or mild to moderate Alzheimer's disease |
| DESPIAD | University College London | CPHPC | Mild Alzheimer's disease |
| GRADUATION | Roche | Gantenerumab | Early Alzheimer's disease |
| INFRONT2 | Alector | AL001 | Frontotemporal dementia |
| INVOKE-2 | Alector | AL002 | Early Alzheimer's disease |
| TRAILBLAZER-ALZ 2 | Eli Lilly | Donanemab | Early Alzheimer's disease |
| VIVIAD | Vivoryon Therapeutics AG | PQ912 | Mild cognitive impairment and mild dementia due to Alzheimer 's Disease |
Last Updated: Wednesday 14 July 2021
